Crystalline forms of a CD73 inhibitor and uses thereof
Crystalline forms of the compound of Formula (I), which modulates the conversion of AMP to adenosine by 5'-nucleotidase, and compositions containing the compound and methods for preparing the crystalline forms, are described herein. The use of such crystalline form of Formula (I) and compositio...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
05.01.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Crystalline forms of the compound of Formula (I), which modulates the conversion of AMP to adenosine by 5'-nucleotidase, and compositions containing the compound and methods for preparing the crystalline forms, are described herein. The use of such crystalline form of Formula (I) and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer and immune-related disorders, that are mediated by 5'-nucleotidase is also provided. |
---|---|
Bibliography: | Application Number: AU20210292195 |